CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 96 filers reported holding CYTOKINETICS INC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $755,000 | -10.5% | 62,400 | -5.0% | 0.05% | -11.3% |
Q1 2017 | $844,000 | +19.2% | 65,700 | -34.6% | 0.05% | -26.4% |
Q1 2016 | $708,000 | -52.7% | 100,500 | -29.8% | 0.07% | -62.3% |
Q4 2015 | $1,497,000 | +187.9% | 143,200 | +83.4% | 0.19% | +180.9% |
Q3 2015 | $520,000 | +249.0% | 78,100 | +250.2% | 0.07% | +223.8% |
Q2 2015 | $149,000 | -24.4% | 22,300 | -14.2% | 0.02% | -53.3% |
Q3 2013 | $197,000 | – | 26,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |